News & Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
PUBLICATION

Comprehensive behavioral testing in the R6/2 mouse model of Huntington’s disease shows no benefit from CoQ10 or minocycline.

May 29, 2010
Read More
PUBLICATION

Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments. Genes, Brain and Behavior

May 27, 2010
Read More
PUBLICATION

On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X(7) receptor antagonist A-438079.

May 25, 2010
Read More
PUBLICATION

MitoPark mice mirror the slow progression of key Parkinson disease symptoms and the L-DOPA response. Genes, Brain and Behavior

March 20, 2010
Read More
PUBLICATION

Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test.

October 25, 2009
Read More
PUBLICATION

Reward-seeking and discrimination deficits displayed by hypodopaminergic mice are prevented in mice lacking dopamine D4 receptors.

October 20, 2009
Read More
PUBLICATION

Acquisition of peak responding

August 28, 2009
Read More
PUBLICATION

Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains.

July 26, 2009
Read More
PUBLICATION

Behavioural and pharmacological mechanisms of bupropion’s anti-smoking effects: recent preclinical and clinical insights.

July 25, 2009
Read More